Saudi Arabia Poised to Become Medical Tourism Hotspot by 2029
Saudi Arabia is set to become a major destination for medical tourism. The market, valued at USD 0.16 billion in 2023, is expected to grow to USD 0.54 billion by 2029, with a compound annual growth rate (CAGR) of 22.52%. The Kingdom offers specialized medical services in fields such as cardiology, orthopaedics, organ transplants, cancer treatment, and fertility treatments. Attracting Patients Through Cost-Effective Solutions
According to a report from ResearchAndMarkets.com, cost-effectiveness is a key factor driving medical tourism. Patients find that medical procedures in Saudi Arabia are significantly cheaper than in their home countries, especially for elective procedures. The cost savings make it an attractive option for non-emergency care, offering substantial financial benefits.
Saudi Arabia is home to advanced medical treatments, making it a preferred destination for specialized care. The government and private healthcare sectors actively promote the country as a medical tourism hub through international collaborations, marketing campaigns, and participation in medical exhibitions. Positive feedback from international patients has reinforced Saudi Arabia's reputation as a trusted medical tourism destination.
Good word of mouth and positive online reviews play a significant role in attracting international patients. Saudi Arabia's medical institutions invest heavily in research and innovation, offering patients access to the latest medical advancements. Additionally, the country's geographical location makes it easily accessible to patients from neighboring Middle Eastern, African, and other regional countries.
Recovery and Wellness Tourism: A Holistic Approach
Saudi Arabia is expanding its medical tourism offerings to include wellness and recovery services. The country offers state-of-the-art rehabilitation centers for post-treatment care. These centers provide physical therapy, occupational therapy, and other specialized services to support patients' recovery.
Saudi Arabia also boasts world-class spa and wellness facilities that cater to patients seeking relaxation and stress relief. Nutritional counseling and dietary planning complement the medical treatments, optimizing recovery. Wellness programs also include mind-body therapies like yoga and meditation, aiding physical and mental recovery.
Saudi Arabia offers unique cultural and spiritual experiences. Patients can visit historical sites, art galleries, and local traditions during their recovery. For many, the religious significance of Saudi Arabia adds a spiritual dimension to their medical journey. Pilgrimages to Mecca and Medina allow patients to combine healing with faith, enhancing their recovery process. Northern and Central Regions Leading the Market
The Northern and Central regions of Saudi Arabia are the primary drivers of the medical tourism market. These areas are home to top-tier, internationally accredited healthcare facilities. The capital city, Riyadh, located in the Central region, attracts numerous medical tourists due to its developed infrastructure and accessibility. These regions specialize in complex surgeries, organ transplants, and advanced treatments, further solidifying their role as medical tourism hubs. Government Support and Vision 2030
Under Saudi Vision 2030, the government has made significant investments in healthcare infrastructure. Development projects include new medical cities and specialized healthcare facilities to meet the growing demand for medical tourism. These efforts aim to make Saudi Arabia a leading medical tourism destination.
Key Medical Institutions in Saudi Arabia
Notable healthcare facilities contributing to the growth of Saudi Arabia's medical tourism market include:
King Abdullah Specialist Children's Hospital
Saudi Centre for Organ Transplantation
Dr. Soliman Fakeeh Hospital
Al Ryan Hospital
Abeer Medical Group
The Saudi Arabia Medical Tourism Market is expected to see substantial growth from 2023 to 2029. The forecasted market value by 2029 is USD 0.54 billion, with a CAGR of 22.52%.
Short link :
Post Views: 9
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arab News
29-04-2025
- Arab News
UAE and Gates Foundation launch $500m maternal health fund for Africa
LONDON: A group of philanthropies including the Gates Foundation has set up a fund backed with nearly $500 million to help save the lives of newborn babies and mothers in sub-Saharan Africa, standing out against a bleak global health funding landscape. The Beginnings Fund was launched on Tuesday in Abu Dhabi, the home of another key backer — the United Arab Emirates' recently established Mohamed Bin Zayed Foundation for Humanity. The project has been in the works for at least a year. But its role has become more important as governments worldwide follow the US in pulling back from international aid, its chief executive Alice Kang'ethe told Reuters in an interview. 'It is an opportune moment,' she said earlier this month, stressing that the fund aimed to work alongside African governments, experts and organizations rather than parachuting in experts or technologies, an approach she said differed from many traditional donor programs. 'Two generations ago... women in the UAE used to die during childbirth. More than half of children did not survive past childhood,' said Tala Al Ramahi at the Mohamed Bin Zayed Foundation, saying the lessons learned in what worked to change those outcomes would help inform the effort. The Beginnings Fund aims to save the lives of 300,000 mothers and newborn babies by 2030, and expand quality care for 34 million mothers and babies. The partners also pledged $100 million in direct investments in maternal and child health, separate to the fund. It plans to operate in Ethiopia, Ghana, Kenya, Malawi, Lesotho, Nigeria, Rwanda, Tanzania, Uganda, and Zimbabwe, focusing on low-cost interventions and personnel in high-burden hospitals. The work will track and target the key reasons babies and mothers die, including infection, severe bleeding for mothers, and respiratory distress for infants. The world has made major progress in reducing newborn and maternal deaths, halving the neonatal mortality rate between 1990 and 2022. But that progress has stagnated or even reversed in nearly all regions in the last few years, according to the World Health Organization, which has warned that aid cuts could make this worse. 'Mothers and newborns should not be dying from causes we know how to prevent,' said Dr. Mekdes Daba, minister of health for Ethiopia, stressing that the majority of deaths are avoidable. Kang'ethe said the Beginnings Fund, like other philanthropies, was getting calls to fill gaps in global aid funding, but remained focused on its long-term aim of changing the trajectory of mother and newborn survival. The fund is also backed by the Children's Investment Fund Foundation, Delta Philanthropies and the ELMA Foundation, among others. It will be led from Nairobi, Kenya.
Asharq Al-Awsat
25-04-2025
- Asharq Al-Awsat
Sudan War Destroys World's Only Research Center on Skin Disease Mycetoma
The world's only research center on mycetoma, a neglected tropical disease common among farmers, has been destroyed in Sudan's two-year war, its director and another expert say. Mycetoma is caused by bacteria or fungus and usually enters the body through cuts. It is a progressively destructive infectious disease of the body tissue, affecting skin, muscle and even bone. It is often characterized by swollen feet, but can also cause barnacle-like growths and club-like hands, AFP said. "The center and all its infrastructure were destroyed during the war in Sudan," Ahmed Fahal, director of the Mycetoma Research Centre (MRC), told AFP. "We lost the entire contents of our biological banks, where there was data from more than 40 years," said Fahal, whose center had treated thousands of patients from Sudan and other countries. "It's difficult to bear." Since April 15, 2023, Sudan's army has been at war with the paramilitary Rapid Support Forces throughout the northeast African country. The MRC is located in the Khartoum area, which the army last month reclaimed from the RSF during a war that has killed tens of thousands of people and uprooted more than 12 million. Sudan's health care system has been left at the "breaking point", according to the World Health Organization. Among the conflict's casualties is now the MRC, established in 1991 under the auspices of the University of Khartoum. It was a rare story of medical success in impoverished Sudan. A video provided by the global Drugs for Neglected Diseases initiative (DNDi) shows collapsed ceilings, shelves overturned, fridges open and documents scattered about. AFP was not able to independently verify the MRC's current condition. The center had grown to include 50 researchers and treat 12,000 patients each year, Fahal said. Mycetoma is listed as a neglected tropical disease by the WHO. The organisms that cause mycetoma also occur in Sudan's neighbors, including Chad and Ethiopia, as well as in other tropical and sub-tropical areas, among them Mexico and Thailand, WHO says. For herders, farmers and other workers depending on manual labor to survive, crippling mycetoma infections can be a life sentence. Drawing on the MRC's expertise, in 2019 the WHO and Sudan's government convened the First International Training Workshop on Mycetoma, in Khartoum. "Today, Sudan, which was at the forefront of awareness of mycetomas, has gone 100 percent backwards," said Dr. Borna Nyaoke-Anoke, DNDi's head of mycetoma.
Arab News
24-04-2025
- Arab News
Sudan war destroys world's only research center on skin disease mycetoma: director
CAIRO: The world's only research center on mycetoma, a neglected tropical disease common among farmers, has been destroyed in Sudan's two-year war, its director and another expert say. Mycetoma is caused by bacteria or fungus and usually enters the body through cuts. It is a progressively destructive infectious disease of the body tissue, affecting skin, muscle and even bone. It is often characterised by swollen feet, but can also cause barnacle-like growths and club-like hands. 'The center and all its infrastructure were destroyed during the war in Sudan,' Ahmed Fahal, director of the Mycetoma Research Center (MRC), told AFP. 'We lost the entire contents of our biological banks, where there was data from more than 40 years,' said Fahal, whose center had treated thousands of patients from Sudan and other countries. 'It's difficult to bear.' Since April 15, 2023, Sudan's army has been at war with the paramilitary Rapid Support Forces throughout the northeast African country. The MRC is located in the Khartoum area, which the army last month reclaimed from the RSF during a war that has killed tens of thousands of people and uprooted more than 12 million. Sudan's health care system has been left at the 'breaking point,' according to the World Health Organization. Among the conflict's casualties is now the MRC, established in 1991 under the auspices of the University of Khartoum. It was a rare story of medical success in impoverished Sudan. A video provided by the global Drugs for Neglected Diseases initiative (DNDi) shows collapsed ceilings, shelves overturned, fridges open and documents scattered about. AFP was not able to independently verify the MRC's current condition. The center had grown to include 50 researchers and treat 12,000 patients each year, Fahal said. Mycetoma is listed as a neglected tropical disease by the WHO. The organisms that cause mycetoma also occur in Sudan's neighbors, including Chad and Ethiopia, as well as in other tropical and sub-tropical areas, among them Mexico and Thailand, WHO says. For herders, farmers and other workers depending on manual labor to survive, crippling mycetoma infections can be a life sentence. Drawing on the MRC's expertise, in 2019 the WHO and Sudan's government convened the First International Training Workshop on Mycetoma, in Khartoum. 'Today, Sudan, which was at the forefront of awareness of mycetomas, has gone 100 percent backwards,' said Dr. Borna Nyaoke-Anoke, DNDi's head of mycetoma.
